Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations

v3.10.0.1
Consolidated Statements of Operations - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Operating expenses        
Research and development $ 5,710,455 $ 4,934,788 $ 15,698,129 $ 12,893,655
General and administrative 2,088,835 1,800,400 6,581,784 6,265,668
Total operating expenses 7,799,290 6,735,188 22,279,913 19,159,323
Loss from operations (7,799,290) (6,735,188) (22,279,913) (19,159,323)
Other income (expense):        
Interest income 174,778 123,960 490,170 245,979
Other expense 0 (905,014) 0 (905,014)
Change in fair value of warrant liabilities 3,246,765 5,941,144 (21,830,377) 9,058,208
Total other income (expense) 3,421,543 5,160,090 (21,340,207) 8,399,173
Net loss $ (4,377,747) $ (1,575,098) $ (43,620,120) $ (10,760,150)
Per share information:        
Net loss per share of common stock, basic and diluted $ (0.06) $ (0.02) $ (0.58) $ (0.22)
Basic and diluted weighted average shares outstanding 77,447,599 64,960,354 74,934,774 49,509,486